-transparent.png){kind=logo}
Two new of the spin-labeled analogues of Rubomycin were studied. It was shown that spin-labeled derivatives were less toxic than the parent compound and had a broad-spectrum antitumor activity. Spin-labeled derivative was clearly less cardiotoxic in the rat model than Rubomycin (Daunorubomycin).
Related Publications
N M Emanuel, and
N P Konovalova, and
R F Diatchkovskaya
November 1982,
Antibiotiki,
N M Emanuel, and
N P Konovalova, and
R F Diatchkovskaya
March 2013,
Mini reviews in medicinal chemistry,
N M Emanuel, and
N P Konovalova, and
R F Diatchkovskaya
December 2011,
Steroids,
N M Emanuel, and
N P Konovalova, and
R F Diatchkovskaya
May 2001,
IDrugs : the investigational drugs journal,
N M Emanuel, and
N P Konovalova, and
R F Diatchkovskaya
May 1998,
Farmaco (Societa chimica italiana : 1989),
N M Emanuel, and
N P Konovalova, and
R F Diatchkovskaya
November 1995,
Mutation research,
N M Emanuel, and
N P Konovalova, and
R F Diatchkovskaya
November 1967,
Journal of medicinal chemistry,
N M Emanuel, and
N P Konovalova, and
R F Diatchkovskaya
August 2014,
Toxicology in vitro : an international journal published in association with BIBRA,
N M Emanuel, and
N P Konovalova, and
R F Diatchkovskaya
May 2017,
Phytotherapy research : PTR,
N M Emanuel, and
N P Konovalova, and
R F Diatchkovskaya
November 2019,
Pharmaceuticals (Basel, Switzerland),
